Form 4: Sylvamo Corp Director Gottung Acquires Dividend Equivalent Units
SEC Form 4
Director Lizanne C. Gottung reports acquisition of dividend equivalent units related to restricted and deferred stock units.
Summary
- Lizanne C. Gottung, a director of Sylvamo Corp, reported the acquisition of 9.2594 dividend equivalent units (DEUs) on October 17, 2024.
- These DEUs are associated with previously granted restricted stock units (RSUs) and deferred stock units (DSUs) under the Sylvamo Corporation Restricted Stock and Deferred Compensation Plan for Non-Employee Directors.
- The DEUs accrued in connection with a dividend paid on Sylvamo Corporation common stock.
- Each DEU represents the right to receive one share of Sylvamo Corporation common stock, subject to vesting.
- Following the transaction, Gottung directly owns 153.0438 DEUs.
- The price of the dividend equivalent units is $86.97.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating normal corporate operations. The sentiment is neutral to slightly positive as it reflects the company's commitment to compensating its directors.
Industry Context
This Form 4 filing is a routine disclosure related to director compensation and dividend accruals, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it reflects the company's ongoing compensation practices for its directors.
Key Dates
| Date | Description |
|---|---|
| 10/17/2024 | Date of transaction: Acquisition of dividend equivalent units. |
| 10/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.